If you invest in the stock market, you must know the complete details of Amanta Healthcare IPO GMP and its share price target 2025, 2026, 2027, 2028, 2029, 2030, 2035, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as Amanta Healthcare IPO GMP date, fundamentals, shareholdings, financial performance, future predictions, and more.
Amanta Healthcare IPO GMP Overview
Amanta Healthcare IPO is launching from September 1 to September 3, 2025. The company is offering shares with a face value of ₹2 each, and the price per share will range between ₹120 and ₹126. The total issue size is around ₹126 crores. The IPO will be listed on both the NSE and the BSE stock exchanges. Different types of investors will get specific portions of the shares: retail investors can apply for up to 35%, qualified institutional buyers (QIBs) up to 50%, and non-institutional investors (NII) up to 15%. The IPO follows a book-built method for pricing.
Amanta Healthcare IPO GMP Details
| IPO Open Date | September 1, 2025 |
| IPO Close Date | September 3, 2025 |
| IPO Listing Date | September 8, 2025 |
| Price Band | ₹120 to ₹126 per share |
| Issue Size | Approx. ₹126 Crores |
| Fresh Issue | Approx. ₹126 Crores |
| Face Value | ₹10 Per Equity Share |
| IPO Listing | NSE & BSE |
| Retail Quota | Up to 35% |
| QIB Quota | Up to 50% |
| NII Quota | Up to 15% |
About Amanta Healthcare Ltd
Amanta Healthcare is a leading Indian pharmaceutical company known for making high-quality medicines and healthcare products that are trusted in hospitals and clinics across the world. The company mainly produces sterile IV fluids, eye drops, antibiotics, injections, and other life-saving medicines that help doctors treat patients safely and effectively. With modern manufacturing plants and strict quality standards, Amanta Healthcare ensures its products meet global healthcare needs. The company also exports its medicines to many countries, making it an important player in the pharmaceutical and healthcare industry.
Fundamental Analysis of Amanta Healthcare
| Market Cap. | ₹489 Cr. |
| ROE | 15.8% |
| ROCE | 15.7% |
| P/E | 46.6 |
| P/B | — |
| Dividend Yield | — |
| Book Value | — |
| Face Value | ₹10 |
| 52-Week High | — |
| 52-Week Low | — |
Also Read: Glenmark Pharmaceuticals Share Price Target
Amanta Healthcare Share Price Target 2025
After analysing past price trends and market performance, it is estimated that the Amanta Healthcare stock price could reach a minimum of ₹130 and potentially achieve a maximum target of ₹200 in the year 2025.
| Year 2025 | Target Price |
|---|---|
| Minimum Price | ₹130 |
| Maximum Price | ₹200 |
Amanta Healthcare Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Amanta Healthcare stock price could reach a minimum of ₹200 and potentially achieve a maximum target of ₹250 in the year 2026.
| Year 2026 | Target Price |
|---|---|
| Minimum Price | ₹200 |
| Maximum Price | ₹250 |
Amanta Healthcare Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Amanta Healthcare stock price could reach a minimum of ₹250 and potentially achieve a maximum target of ₹320 in the year 2027.
| Year 2027 | Target Price |
|---|---|
| Minimum Price | ₹250 |
| Maximum Price | ₹320 |
Amanta Healthcare Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Amanta Healthcare stock price could reach a minimum of ₹320 and potentially achieve a maximum target of ₹400 in the year 2028.
| Year 2028 | Target Price |
|---|---|
| Minimum Price | ₹320 |
| Maximum Price | ₹400 |
Amanta Healthcare Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Amanta Healthcare stock price could reach a minimum of ₹420 and potentially achieve a maximum target of ₹500 in the year 2029.
| Year 2029 | Target Price |
|---|---|
| Minimum Price | ₹420 |
| Maximum Price | ₹500 |
Amanta Healthcare Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Amanta Healthcare stock price could reach a minimum of ₹500 and potentially achieve a maximum target of ₹600 in the year 2030.
| Year 2030 | Target Price |
|---|---|
| Minimum Price | ₹500 |
| Maximum Price | ₹600 |
Also Read: Dr Reddy Share Price Target
Shareholding Pattern of Amanta Healthcare
| Retail & Others | 0% |
| Promoters | 0% |
| Foreign Institutions | 0% |
| Mutual Funds | 0% |
| Other Domestic Institutions | 0% |
Should You Invest in Amanta Healthcare Stock?
| Year | Target Price (₹) |
|---|---|
| 2025 | 130 – 200 |
| 2026 | 200 – 250 |
| 2027 | 250 – 320 |
| 2028 | 320 – 400 |
| 2029 | 420 – 500 |
| 2030 | 500 – 600 |
| 2035 | 1000 – 1500 |
| 2040 | 2000 – 3000 |
| 2050 | 8000 – 9000 |
Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Amanta Healthcare stock.
Opportunities
- Strong presence in the pharmaceutical and healthcare sector, which is always in demand.
- Focus on export markets helps the company earn from global customers.
- Wide product range including IV fluids, medicines, and healthcare solutions increases business stability.
- Healthcare is a defensive sector, meaning demand stays strong even in tough economic times.
- Growth potential as India’s healthcare industry expands rapidly with rising medical needs.
Risks
- High competition from large pharma companies may reduce market share.
- Changes in government policies or regulations can affect profitability.
- Currency fluctuations can impact income from international exports.
- Rising raw material costs may lower margins.
- Any quality or compliance issues in production can hurt brand trust and stock performance.
Key Competitors of Amanta Healthcare
Key competitors or peer companies of Amanta Healthcare Limited are Cipla, Sun Pharmaceutical Industries, Lupin, Dr. Reddy’s Laboratories, Zydus Lifesciences, Glenmark Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Cadila Pharmaceuticals, Intas Pharmaceuticals, Natco Pharma, Ajanta Pharma, Abbott Healthcare (India), Zuventus Healthcare, and Entero Healthcare.
Also Read: Anthem BioSciences Share Price Target
FAQs
Q. What is the price target for Amanta Healthcare in 2025?
The price target for Amanta Healthcare in 2025 is projected to range from ₹130 to ₹200.
Q. What is the price target for Amanta Healthcare in 2030?
The price target for Amanta Healthcare in 2030 is projected to range from ₹500 to ₹600.
Q. What is the price target for Amanta Healthcare in 2035?
The price target for Amanta Healthcare in 2035 is projected to range from ₹1000 to ₹1500.
Q. What is the Amanta Healthcare share price target 2040?
The Amanta Healthcare share price target 2040 is projected to range from ₹2000 to ₹3000.
Q. What is the Amanta Healthcare share price target 2050?
The Amanta Healthcare share price target 2050 is projected to range from ₹8000 to ₹9000.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
We have more than 5 years of experience in the stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
